Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
Mobile Cardiac Telemetry (MCT) is a kind of real-time ECG monitoring system in which the patient wears a device that monitors their ECG (electrocardiogram) data on an outpatient basis continuedly. This technology represents the reliable & efficient method to monitor a cardiac patient during the day and during sleep. The increasing prevalence of cardiac disorders and increasing focus on wearable products for real-time patient monitoring are a key factor that are expected to drive the market growth in the coming years. Mobile Cardiac Telemetry (MCT) is becoming more common as the device is far less labour intensive for the patient as compared to the traditional Event Monitor.
Increasing prevalence of cardiovascular disorders has improved awareness about the benefits of Mobile Cardiac Telemetry (MCT) devices, is driving the market growth. For instance, as indicated by Centers for Disease Control and Prevention (CDC), in 2017, 800,000 deaths were reported due to cardiac disorders in the U.S., which is also the leading cause of death in the country. Therefore, the increasing number of cardiac conditions is boosting the need for mobile cardiac telemetry systems.
Besides, governments of various countries are focusing on lessening the number of cardiac conditions and develop methods to diagnose indications and taking initiatives to increase awareness, among healthcare providers and patients, of equipment that can monitor cardiac conditions and the risks associated with them. Moreover, increasing adoption of telemedicine and the growing need for real-time patient monitoring for convenience have been offering huge growth opportunities to the healthcare systems and software companies to build wearable monitoring products for patients. However, the stringent regulations and product recalls associated with product failure is anticipated to hinder market growth to some extent.
The report analyses the mobile cardiac telemetry systems market based on technology, end user and geography. Mobile cardiac telemetry market based on technology, the market is segmented into lead based and patch based. The major end users of the mobile cardiac telemetry systems are hospitals, cardiac centers etc. Based on geography, the global Antifreeze Proteins market is segmented into North America, Europe, Asia Pacific and Rest of the World.
Mobile cardiac telemetry market based on technology, the market is segmented into lead based and patch based. lead-based mobile cardiac telemetry are light weighted, user-friendly, and therefore preferred among several patients. The lead-based technology was major shareholder of the market. Moreover, the patch-based segment is anticipated to witness the fastest growth over the forecast period owing to advances in the technology of wearable cardiac monitors.
The major end users of the mobile cardiac telemetry systems are hospitals, cardiac centers etc. Hospitals accounted for the major share of the market, whereas, cardiac centre segment is anticipated to witness the fastest growth over the forecast period owing to increased number of cardiac centers and easy availability of surgeons under these facilities.
Based on geography, the global Antifreeze Proteins market is segmented into North America, Europe, Asia Pacific and Rest of the World. North America accounted for the largest share of the mobile cardiac telemetry systems market in followed by Europe and Asia Pacific. The large share in the North American region is mainly attributed to the rising incidence of cardiovascular diseases in the region, technological advancements in wearable diseases, and high adoption of advanced medical systems in the region. Whereas, rapidly growing aging population, improving healthcare infrastructure, and increasing cases of cardiovascular diseases in Asia Pacific region are driving the growth of the Asia Pacific market.
Some of the major players operating in this market includes BioTelemetry, Inc., ScottCare, Biotricity Inc., Welch Allyn, Applied Cardiac Systems Inc., Medicomp Inc., Preventice Solutions, Telerhythmics LLC, Zoll Medical Corporation iRhythm Technologies, Inc.among others. Key strategies adopted by most of the key industry players include new product launch, mergers, acquisitions, and business expansion to strengthen product portfolio and maintain their market position.
June 2019 : ZOLL implemented the recent technology in order to improve the management of patients with acute heart failure. This is designed to assist medical doctors, enhance results in patients with fluid management complications and decrease hospitalizations.
January 2019: BioTelemetry, Inc acquired Geneva Healthcare, Inc. which is the leading provider of remote monitoring for implantable cardiac devices.
May 2018: Preventice Solutions, Inc. introduced BodyGuardian MINI. It is easy to use and reliable based on its small size and reusable, waterproof design. This device gives a wearable patch which is able to move and reapply by the patient.
December 2015: ScottCare introduced 3-in-1 TeleSense RCM. 3-in-1 TeleSense RCM is a cardiac Rhythm Monitor offers full MCT, holter functionality and cellular events. The device transfer arrhythmia occurrences, local Wi-Fi, precision, auto-trigger and automotive transmission.
The report analyses the mobile cardiac telemetry systems market based on technology end user and geography. Mobile cardiac telemetry market based on technology, the market is segmented into lead based and patch based. The major end users of the mobile cardiac telemetry systems are hospitals, cardiac centers etc. Based on geography, the global Antifreeze Proteins market is segmented into North America, Europe, Asia Pacific and Rest of the World.
Some of the major players operating in this market includes BioTelemetry, Inc., ScottCare, Biotricity Inc., Welch Allyn, Applied Cardiac Systems Inc., Medicomp Inc., Preventice Solutions, Telerhythmics LLC, Zoll Medical Corporation iRhythm Technologies, Inc. among others.
Why to Buy This Report
